Research tool will predict disease severity and therapeutic response
Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen
Updated Date: Mon, 28 Sep 2020 00:00:00 EDT
Updated Date: Mon, 28 Sep 2020 00:00:00 EDT
Marksans expands metformin recall as carcinogen contamination worries continue to grow kblankenship Mon, 10/05/2020 – 18:39
Mylan, Hikma versions of injectable diuretic recommended for recall by Kentucky researchers kblankenship Mon, 10/05/2020 – 17:14
FDA career experts will handle coronavirus vaccine reviews, commissioner says esagonowsky Mon, 10/05/2020 – 15:25
The government’s plan to build or refurbish 40 hospitals in England will fall short of what is required […]
Yamey and Walensky draw on the experience of the United States to show the risks of outbreaks when […]
Teva back on the hook for $235M to GSK for heart drug infringement esagonowsky Mon, 10/05/2020 – 11:22